Phase I study of SGN-CD352A in patients with relapsed or refractory multiple myeloma - Regional Cancer Care Associates LLC

Clinical Trials

Phase I study of SGN-CD352A in patients with relapsed or refractory multiple myeloma

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
Seattle Genetics
Protocol Number
Seaettle Genetics SGN352-001
Cancer Diagnosis
To Learn More Call
201-510-0910